0.022406 0.000000 0.000000 0.000000 0.022406 0.000000 0.000000 0.000000 0.007433 0.00000 0.00000 0.00000 Hohenester, E. Sasaki, T. Timpl, R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 44.630 44.630 134.540 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C8 H15 N O6 221.208 2-acetamido-2-deoxy-beta-D-glucopyranose D-saccharide, beta linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 6 228 232 10.1038/6669 10074941 Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. 1999 UK Embo J. EMJODG 0897 0261-4189 17 1606 Mac-2 Binding Protein is a Cell-Adhesive Protein of the Extracellular Matrix which Self-Assembles Into Ring-Like Structures and Binds Beta1 Integrins, Collagens and Fibronectin 1998 NE Trends Biochem.Sci. TBSCDB 0946 0968-0004 19 5 The Srcr Superfamily: A Family Reminiscent of the Ig Superfamily 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 293 1 IMAGE PLATE 1998-07-07 MARRESEARCH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE ELLIOTT GX-21 12705.093 MAC-2 BINDING PROTEIN SCAVENGER RECEPTOR CYSTEINE-RICH (SRCR) DOMAIN N-TERMINAL APLA 1 man polymer 221.208 2-acetamido-2-deoxy-beta-D-glucopyranose 1 man non-polymer 18.015 water 57 nat water TUMOR-ASSOCIATED ANTIGEN 90K no no APLAVNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASVVCRALGFENATQALGRAAFGQGSGPIMLDEVQCT GTEASLADCKSLGWLKSNCRHERDAGVVCTNETRSTHTL APLAVNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASVVCRALGFENATQALGRAAFGQGSGPIMLDEVQCT GTEASLADCKSLGWLKSNCRHERDAGVVCTNETRSTHTL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo human Homo sample 293-EBNA 9606 KIDNEY Homo sapiens 293-EBNA 9606 Homo sapiens PCEP-PU 1 2.6 50 TWO DERIVATIVES (SMCL3 AND UO2SO4) WERE USED AT 3.0 A 6.0 pH 6.0 chem_comp entity pdbx_chem_comp_identifier pdbx_entity_nonpoly pdbx_unobs_or_zero_occ_atoms struct_conn struct_site struct_site_gen repository Initial release Carbohydrate remediation repository Remediation Version format compliance Non-polymer description Version format compliance Advisory Data collection Derived calculations Structure summary 1 0 1999-05-18 1 1 2008-03-24 1 2 2011-07-13 1 3 2020-07-29 _chem_comp.name _chem_comp.type _entity.pdbx_description _pdbx_entity_nonpoly.name _struct_conn.pdbx_leaving_atom_flag _struct_conn.pdbx_role _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_asym_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_asym_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id DGlcpNAcb N-acetyl-b-D-glucopyranosamine b-D-GlcpNAc GlcNAc Y BNL 1998-10-23 REL NAG 2-acetamido-2-deoxy-beta-D-glucopyranose HOH water NAG 201 2 NAG NAG 201 A HOH 301 3 HOH HOH 301 A HOH 302 3 HOH HOH 302 A HOH 303 3 HOH HOH 303 A HOH 304 3 HOH HOH 304 A HOH 305 3 HOH HOH 305 A HOH 306 3 HOH HOH 306 A HOH 307 3 HOH HOH 307 A HOH 308 3 HOH HOH 308 A HOH 309 3 HOH HOH 309 A HOH 310 3 HOH HOH 310 A HOH 311 3 HOH HOH 311 A HOH 312 3 HOH HOH 312 A HOH 313 3 HOH HOH 313 A HOH 314 3 HOH HOH 314 A HOH 315 3 HOH HOH 315 A HOH 316 3 HOH HOH 316 A HOH 317 3 HOH HOH 317 A HOH 318 3 HOH HOH 318 A HOH 319 3 HOH HOH 319 A HOH 320 3 HOH HOH 320 A HOH 321 3 HOH HOH 321 A HOH 322 3 HOH HOH 322 A HOH 323 3 HOH HOH 323 A HOH 324 3 HOH HOH 324 A HOH 325 3 HOH HOH 325 A HOH 326 3 HOH HOH 326 A HOH 327 3 HOH HOH 327 A HOH 328 3 HOH HOH 328 A HOH 329 3 HOH HOH 329 A HOH 330 3 HOH HOH 330 A HOH 331 3 HOH HOH 331 A HOH 332 3 HOH HOH 332 A HOH 333 3 HOH HOH 333 A HOH 334 3 HOH HOH 334 A HOH 335 3 HOH HOH 335 A HOH 336 3 HOH HOH 336 A HOH 337 3 HOH HOH 337 A HOH 338 3 HOH HOH 338 A HOH 339 3 HOH HOH 339 A HOH 340 3 HOH HOH 340 A HOH 341 3 HOH HOH 341 A HOH 342 3 HOH HOH 342 A HOH 343 3 HOH HOH 343 A HOH 344 3 HOH HOH 344 A HOH 345 3 HOH HOH 345 A HOH 346 3 HOH HOH 346 A HOH 347 3 HOH HOH 347 A HOH 348 3 HOH HOH 348 A HOH 349 3 HOH HOH 349 A HOH 350 3 HOH HOH 350 A HOH 351 3 HOH HOH 351 A HOH 352 3 HOH HOH 352 A HOH 353 3 HOH HOH 353 A HOH 354 3 HOH HOH 354 A HOH 355 3 HOH HOH 355 A HOH 356 3 HOH HOH 356 A HOH 357 3 HOH HOH 357 A n 1 -3 A n 2 -2 A n 3 -1 A ALA 0 n 4 ALA 0 A VAL 1 n 5 VAL 1 A ASN 2 n 6 ASN 2 A ASP 3 n 7 ASP 3 A GLY 4 n 8 GLY 4 A ASP 5 n 9 ASP 5 A MET 6 n 10 MET 6 A ARG 7 n 11 ARG 7 A LEU 8 n 12 LEU 8 A ALA 9 n 13 ALA 9 A ASP 10 n 14 ASP 10 A GLY 11 n 15 GLY 11 A GLY 12 n 16 GLY 12 A ALA 13 n 17 ALA 13 A THR 14 n 18 THR 14 A ASN 15 n 19 ASN 15 A GLN 16 n 20 GLN 16 A GLY 17 n 21 GLY 17 A ARG 18 n 22 ARG 18 A VAL 19 n 23 VAL 19 A GLU 20 n 24 GLU 20 A ILE 21 n 25 ILE 21 A PHE 22 n 26 PHE 22 A TYR 23 n 27 TYR 23 A ARG 24 n 28 ARG 24 A GLY 25 n 29 GLY 25 A GLN 26 n 30 GLN 26 A TRP 27 n 31 TRP 27 A GLY 28 n 32 GLY 28 A THR 29 n 33 THR 29 A VAL 30 n 34 VAL 30 A CYS 31 n 35 CYS 31 A ASP 32 n 36 ASP 32 A ASN 33 n 37 ASN 33 A LEU 34 n 38 LEU 34 A TRP 35 n 39 TRP 35 A ASP 36 n 40 ASP 36 A LEU 37 n 41 LEU 37 A THR 38 n 42 THR 38 A ASP 39 n 43 ASP 39 A ALA 40 n 44 ALA 40 A SER 41 n 45 SER 41 A VAL 42 n 46 VAL 42 A VAL 43 n 47 VAL 43 A CYS 44 n 48 CYS 44 A ARG 45 n 49 ARG 45 A ALA 46 n 50 ALA 46 A LEU 47 n 51 LEU 47 A GLY 48 n 52 GLY 48 A PHE 49 n 53 PHE 49 A GLU 50 n 54 GLU 50 A ASN 51 n 55 ASN 51 A ALA 52 n 56 ALA 52 A THR 53 n 57 THR 53 A GLN 54 n 58 GLN 54 A ALA 55 n 59 ALA 55 A LEU 56 n 60 LEU 56 A GLY 57 n 61 GLY 57 A ARG 58 n 62 ARG 58 A ALA 59 n 63 ALA 59 A ALA 60 n 64 ALA 60 A PHE 61 n 65 PHE 61 A GLY 62 n 66 GLY 62 A GLN 63 n 67 GLN 63 A GLY 64 n 68 GLY 64 A SER 65 n 69 SER 65 A GLY 66 n 70 GLY 66 A PRO 67 n 71 PRO 67 A ILE 68 n 72 ILE 68 A MET 69 n 73 MET 69 A LEU 70 n 74 LEU 70 A ASP 71 n 75 ASP 71 A GLU 72 n 76 GLU 72 A VAL 73 n 77 VAL 73 A GLN 74 n 78 GLN 74 A CYS 75 n 79 CYS 75 A THR 76 n 80 THR 76 A GLY 77 n 81 GLY 77 A THR 78 n 82 THR 78 A GLU 79 n 83 GLU 79 A ALA 80 n 84 ALA 80 A SER 81 n 85 SER 81 A LEU 82 n 86 LEU 82 A ALA 83 n 87 ALA 83 A ASP 84 n 88 ASP 84 A CYS 85 n 89 CYS 85 A LYS 86 n 90 LYS 86 A SER 87 n 91 SER 87 A LEU 88 n 92 LEU 88 A GLY 89 n 93 GLY 89 A TRP 90 n 94 TRP 90 A LEU 91 n 95 LEU 91 A LYS 92 n 96 LYS 92 A SER 93 n 97 SER 93 A ASN 94 n 98 ASN 94 A CYS 95 n 99 CYS 95 A ARG 96 n 100 ARG 96 A HIS 97 n 101 HIS 97 A GLU 98 n 102 GLU 98 A ARG 99 n 103 ARG 99 A ASP 100 n 104 ASP 100 A ALA 101 n 105 ALA 101 A GLY 102 n 106 GLY 102 A VAL 103 n 107 VAL 103 A VAL 104 n 108 VAL 104 A CYS 105 n 109 CYS 105 A THR 106 n 110 THR 106 A ASN 107 n 111 ASN 107 A GLU 108 n 112 GLU 108 A THR 109 n 113 THR 109 A n 114 110 A n 115 111 A n 116 112 A n 117 113 A THR 114 n 118 THR 114 A LEU 115 n 119 LEU 115 A author_defined_assembly 1 monomeric A ASN 51 GLYCOSYLATION SITE A ASN 55 ASN 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ARG 7 A O ARG 11 A N GLU 20 A N GLU 24 A O GLY 17 A O GLY 21 A N VAL 103 A N VAL 107 A O GLY 102 A O GLY 106 A N LEU 56 A N LEU 60 A O ILE 21 A O ILE 25 A N GLY 28 A N GLY 32 1 A ALA -3 A ALA 1 1 Y 1 A PRO -2 A PRO 2 1 Y 1 A LEU -1 A LEU 3 1 Y 1 A ARG 110 A ARG 114 1 Y 1 A SER 111 A SER 115 1 Y 1 A THR 112 A THR 116 1 Y 1 A HIS 113 A HIS 117 1 Y PARHCSDX.PRO PARAM11.WAT PARAM3_MOD.CHO 20 0.218 0.186 0.186 2.00 8.00 934 9649 10 99.6 RANDOM 100000 0 1 INDIVIDUAL RESTRAINED, RMS BONDS 3.5 A**2 FREE R-FACTOR 0 MIRAS 6.0 0.18 2.00 8.00 57 903 14 0 832 0.008 1.5 1.0 2.0 2.0 4.0 0.277 0.27 2.09 114 1056 8 10 100.0 15 2.00 20.0 1BY2 9843 0 0.069 1 7.3 6.2 99.6 0.186 2.00 2.11 3.7 1 6.0 100.0 data reduction MOSFLM data scaling SCALA (CCP4) model building CCP4 refinement X-PLOR 3.84 data scaling CCP4 (SCALA) phasing CCP4 MAC-2 BINDING PROTEIN STRUCTURE OF M2BP SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN 1 N N 2 N N 3 N N A LEU 37 A LEU 41 HELX_P A ALA 46 A ALA 50 1 1 10 A LEU 82 A LEU 86 HELX_P A ASP 84 A ASP 88 5 2 3 A HIS 97 A HIS 101 HELX_P A ARG 99 A ARG 103 5 3 3 disulf 2.021 A CYS 31 A SG CYS 35 1_555 A CYS 95 A SG CYS 99 1_555 disulf 2.026 A CYS 44 A SG CYS 48 1_555 A CYS 105 A SG CYS 109 1_555 disulf 2.024 A CYS 75 A SG CYS 79 1_555 A CYS 85 A SG CYS 89 1_555 covale 1.444 one N-Glycosylation A ASN 51 A ND2 ASN 55 1_555 A NAG 201 B C1 NAG 1_555 EXTRACELLULAR MODULE EXTRACELLULAR MODULE, SCAVENGER RECEPTOR, TUMOUR-ASSOCIATED ANTIGEN, EXTRACELLULAR MATRIX, GLYCOSYLATED PROTEIN LG3BP_HUMAN UNP 1 1 Q08380 MTPPRLFWVWLLVAGTQGVNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASVVCRALGFENATQALGRAAFG QGSGPIMLDEVQCTGTEASLADCKSLGWLKSNCRHERDAGVVCTNETRSTHTLDLSRELSEALGQIFDSQRGCDLSISVN VQGEDALGFCGHTVILTANLEAQALWKEPGSNVTMSVDAECVPMVRDLLRYFYSRRIDITLSSVKCFHKLASAYGARQLQ GYCASLFAILLPQDPSFQMPLDLYAYAVATGDALLEKLCLQFLAWNFEALTQAEAWPSVPTDLLQLLLPRSDLAVPSELA LLKAVDTWSWGERASHEEVEGLVEKIRFPMMLPEELFELQFNLSLYWSHEALFQKKTLQALEFHTVPFQLLARYKGLNLT EDTYKPRIYTSPTWSAFVTDSSWSARKSQLVYQSRRGPLVKYSSDYFQAPSDYRYYPYQSFQTPQHPSFLFQDKRVSWSL VYLPTIQSCWNYGFSCSSDELPVLGLTKSGGSDRTIAYENKALMLCEGLFVADVTDFEGWKAAIPSALDTNSSKSTSSFP CPAGHFNGFRTVIRPFYLTNSSGVD 19 133 1BY2 1 115 Q08380 A 1 5 119 4 2 anti-parallel anti-parallel anti-parallel anti-parallel A MET 6 A MET 10 A ALA 9 A ALA 13 A GLN 16 A GLN 20 A ILE 21 A ILE 25 A GLY 102 A GLY 106 A CYS 105 A CYS 109 A ALA 52 A ALA 56 A LEU 56 A LEU 60 A GLU 20 A GLU 24 A TYR 23 A TYR 27 A GLN 26 A GLN 30 A THR 29 A THR 33 96 P 43 21 2